|
|
|
Volumn 26, Issue 5 SUPPL. 17, 1999, Pages 49-54
|
|
Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
DOCETAXEL;
ESTRAMUSTINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
ADVANCED CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RESISTANCE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CLINICAL TRIALS;
ESTRAMUSTINE;
HUMANS;
MALE;
NEOADJUVANT THERAPY;
NEOPLASMS, HORMONE-DEPENDENT;
PACLITAXEL;
PROSTATIC NEOPLASMS;
TAXOIDS;
|
|
EID: 0033429148
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (18)
|
|
References (31)
|
